scispace - formally typeset
K

Keisuke Kojima

Researcher at Kumamoto University

Publications -  19
Citations -  293

Keisuke Kojima is an academic researcher from Kumamoto University. The author has contributed to research in topics: Bronchoalveolar lavage & Pulmonary function testing. The author has an hindex of 8, co-authored 18 publications receiving 258 citations.

Papers
More filters
Journal ArticleDOI

Successful treatment of primary pulmonary angiosarcoma.

TL;DR: The case of a patient with primary pulmonary angiosarcoma who responded to a combination of radiotherapy and immunotherapy with recombinant interleukin-2 is reported, and the patient remains well without signs of recurrence 1 year after initial presentation.
Journal ArticleDOI

Galectin-9 expands immunosuppressive macrophages to ameliorate T-cell-mediated lung inflammation.

TL;DR: The present results indicate that Gal‐9 expands immunosuppressive CD11b+Ly‐6ChighF4/80+ BALF Mϕ to ameliorate Th1/Th17 cell‐mediated hypersensitivity pneumonitis.
Journal ArticleDOI

Galectin-9 attenuates acute lung injury by expanding CD14- plasmacytoid dendritic cell-like macrophages.

TL;DR: Gal-9 attenuates ALI by expanding CD14(-)CD11b(+)Gr-1(+) pDC-like macrophages by preferentially suppressing macrophage functions to release proinflammatory cytokines through TLR4 and TLR2 down-regulation.
Journal ArticleDOI

Favorable outcome with hemoperfusion of polymyxin B-immobilized fiber column for rapidly progressive interstitial pneumonia associated with clinically amyopathic dermatomyositis: report of three cases

TL;DR: It is shown that PMX-DHP treatment could be effective in the management of RPIP in patients with C-ADM in combination with conventional therapy, and the abnormal shadows in chest high-resolution computed tomography scans gradually decreased.
Journal ArticleDOI

Successful Treatment of Severe Amiodarone Pulmonary Toxicity With Polymyxin B-Immobilized Fiber Column Direct Hemoperfusion

TL;DR: This case study presents a case study of a patient with severe APT treated with PMX-DHP with complete recovery, and it is speculated that PMx-D HP could be a new treatment strategy for severeAPT.